Statistics

Total Visits

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study100

Select a period of time:

Number of views in the range

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study21

Views

Views
September 20256
October 20253
November 20255
December 20253
January 20262
February 20260
March 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil8
United States4
Argentina2
Germany1
Ecuador1
Egypt1
Finland1
United Kingdom1
El Salvador1
Zambia1
 

Top cities views

Views
Ashburn2
Americana1
Cairo1
Caxias do Sul1
Estância Velha1
Fortaleza1
Frankfurt am Main1
Hacienda Ibarra1
Helsinki1
Passos1